Clinical trial
Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating…
NCT00005863 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00005863 |
|---|---|
| Title | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia |
| Official title | Protocol for Patients With High Risk (Resistant, Refractory, Relapsed or Adverse Cytogenetic) AML |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cytarabine, daunorubicin hydrochloride, etoposide, fludarabine phosphate, tretinoin |
| Start date | Aug 1, 1998 |
| Completion | Dec 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: